Treatment for Eustachian Tube Dysfunction (ETD)

Waitlist Available · 18+ · All Sexes · Los Angeles, CA

Effect of Novel Exhalational Delivery System With Fluticasone (EDS-FLU) on Eustachian Tube Dysfunction (ETD)

See full description

About the trial for Eustachian Tube Dysfunction (ETD)

Treatment Groups

This trial involves 2 different treatments. Treatment is the primary treatment being studied. Participants will all receive the same treatment. Some patients will receive a placebo treatment. The treatments being tested are in Phase 2 and have already been tested with other people.

Control Group 1
Placebo Nasal Spray
Control Group 2
Fluticasone Propionate 93 MCG/1 ACTUATION Nasal Spray


This trial is for patients born any sex aged 18 and older. There are 5 eligibility criteria to participate in this trial as listed below.

Inclusion & Exclusion Checklist
Mark “yes” if the following statements are true for you:
Age greater than or equal to 18 years old, <80 years old
You have symptoms in one or both ears for at least 3 months.\n show original
ETDQ-7 score >14.5
Type B, C, or As tympanometry
You are female and of childbearing potential show original
View All
Odds of Eligibility
Be sure to apply to 2-3 other trials, as you have a low likelihood of qualifying for this one.Apply To This Trial
Similar Trials

Approximate Timelines

Please note that timelines for treatment and screening will vary by patient
Screening: ~3 weeks
Treatment: varies
Reporting: visit 3 (week 12)
This trial has approximate timelines as follows: 3 weeks for initial screening, variable treatment timelines, and reporting: visit 3 (week 12).
View detailed reporting requirements
Trial Expert
Connect with the researchersHop on a 15 minute call & ask questions about:
- What options you have available- The pros & cons of this trial
- Whether you're likely to qualify- What the enrollment process looks like

Measurement Requirements

This trial is evaluating whether Treatment will improve 1 primary outcome in patients with Eustachian Tube Dysfunction (ETD). Measurement will happen over the course of visit 3 (week 12).

7-Item Eustachian Tube Dysfunction Questionnaire (ETDQ-7)
Eustachian tube dysfunction symptoms measured by the validated quality of life 7-Item Eustachian Tube Dysfunction Questionnaire (ETDQ-7) at visit 3. The scale is from 1 (no problem) to 7 (severe problem).

Who is running the study

Principal Investigator
A. W.
Arthur Wu, MD
Cedars-Sinai Medical Center

Patient Q & A Section

Ask a question about the study

Other questions from users

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any geographic restrictions to consider when applying for this trial?

Patients from any state can participate in this trial, so long as they are able to attend all treatment sessions.

Will my insurance cover participating in this trial?

In order to understand how insurance coverage works for this trial, you will need to contact the study coordinator.

See if you qualify for this trial
Get access to this novel treatment for Eustachian Tube Dysfunction (ETD) by sharing your contact details with the study coordinator.